Nicolas Hohmann
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Hepatology top 5%
- Hepatitis C virus research
Papers in
- Pharmacology 12
- Pharmacogenetics and Drug Metabolism 12
- Antibiotics Pharmacokinetics and Efficacy 5
- Oncology 10
- CAR-T cell therapy research 3
- Co-authors
- Gerd Mikus (28 shared papers)Walter E. Haefeli (27 shared papers)Jürgen Burhenne (15 shared papers)Alexandra Carls (7 shared papers)Antje Blank (9 shared papers)David Czock (1 shared paper)Stephan Urban (3 shared papers)Matthias Schwab (3 shared papers)
- Journals
- British Journal of Clinical Pharmacology (4 papers)Clinical and Translational Science (3 papers)Clinical Pharmacokinetics (3 papers)Journal of Clinical Oncology (2 papers)Journal of Hepatology (2 papers)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Nicolas Hohmann
35 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 91
- Pharmacology 223
- Hepatology 137
- Toxicology 57
- Oncology 243
- Epidemiology 254
Countries citing papers authored by Nicolas Hohmann
This map shows the geographic impact of Nicolas Hohmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Hohmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Hohmann more than expected).
Fields of papers citing papers by Nicolas Hohmann
This network shows the impact of papers produced by Nicolas Hohmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Hohmann. The network helps show where Nicolas Hohmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Nicolas Hohmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 172 | |
| 2 | 2013 | 77 | |
| 3 | 2014 | 72 | |
| 4 | 2017 | 66 | |
| 5 | 2021 | 62 | |
| 6 | 2017 | 62 | |
| 7 | 2014 | 61 | |
| 8 | 2016 | 59 | |
| 9 | 2012 | 59 | |
| 10 | 2019 | 54 | |
| 11 | 2016 | 49 | |
| 12 | 2012 | 48 | |
| 13 | 2016 | 34 | |
| 14 | 2016 | 23 | |
| 15 | 2017 | 19 | |
| 16 | 2015 | 16 | |
| 17 | 2016 | 15 | |
| 18 | 2019 | 13 | |
| 19 | 2020 | 12 | |
| 20 | 2016 | 12 |
About Nicolas Hohmann
Nicolas Hohmann is a scholar working on Pharmacology, Oncology, Pharmacology, Epidemiology and Infectious Diseases, having authored 36 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (12 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Antifungal resistance and susceptibility (4 papers), Hepatitis B Virus Studies (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Phytochemistry and Bioactive Compounds (3 papers), CAR-T cell therapy research (3 papers) and Cancer Research and Treatments (3 papers). The work is most often cited by research in Pharmacology (223 citations), Hepatology (137 citations), Toxicology (57 citations), Oncology (243 citations) and Epidemiology (254 citations). Nicolas Hohmann has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Gerd Mikus, Walter E. Haefeli, Jürgen Burhenne, Alexandra Carls, Antje Blank, David Czock, Stephan Urban, Matthias Schwab, Alexander I. Alexandrov and Mathias Haag. Their work appears in journals such as British Journal of Clinical Pharmacology, Clinical and Translational Science, Clinical Pharmacokinetics, Journal of Clinical Oncology and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.